Roche launches Elecsys PRO-C3 test for liver fibrosis Ruchika Sharma6 May 2025 11:30 AM ISTBasel: Roche has announced the launch of its ElecsysPRO-C3 test, a new diagnostic solution designed to assess the severity of liver fibrosis in...
EMA Committee recommends EU label update for Roche Phesgo to allow administration outside of clinical settings Ruchika Sharma4 May 2025 1:30 PM ISTBasel: Roche has announced that the European Medicines Agency's Committee for Medicinal Products for Human Use (CHMP) has issued a positive...
Roche secures USFDA Breakthrough Device Designation for AI-driven companion diagnostic for non small cell lung cancer Ruchika Sharma29 April 2025 11:45 AM ISTBasel: Roche has announced that the VENTANA TROP2 (EPR20043) RxDx Device for non-small cell lung cancer has received Breakthrough Device...
Roche gets CE Mark for Chest Pain Triage algorithm Ruchika Sharma25 April 2025 1:30 PM ISTBasel: Roche has announced the introduction of its Chest Pain Triage algorithm as part of the navify Algorithm Suite.Developed in collaboration...
Roche to infuse USD 50 billion in pharma, diagnostics in US over next five years Ruchika Sharma22 April 2025 10:30 AM ISTBasel: Roche has announced today that it will invest USD 50 billion into the United States of America in the next five years. These investments...
Roche Columvi gets European Commission nod as bispecific antibody for diffuse large B-cell lymphoma after initial therapy Ruchika Sharma14 April 2025 12:30 PM ISTBasel: Roche has announced that the company has received approval from the European Commission for Columvi (glofitamab) in...
Roche, Zealand Pharma ink pact to co-develop, co-commercialise petrelintide as foundational therapy for obesity Ruchika Sharma14 March 2025 1:30 PM ISTBasel: Roche has announced that it has entered into an exclusive collaboration and licensing agreement with Zealand Pharma. Under the terms of this...
Roche Gazyva application accepted by USFDA for lupus nephritis Ruchika Sharma5 March 2025 1:45 PM ISTGazyva/Gazyvaro is an anti-CD20 monoclonal antibody in a randomised phase III study to demonstrate a CRR benefit in lupus nephritis.
Roche bags USFDA nod for companion diagnostic to identify patients with HER2-ultralow metastatic breast cancer eligible for Enhertu Ruchika Sharma1 Feb 2025 12:30 PM ISTBasel: Roche has announced that the U.S. Food and Drug Administration (FDA) has approved a label expansion for the PATHWAY anti-HER2/neu (4B5)...
Roche names Wafaa Mamilli as Chief Digital Technology Officer Ruchika Sharma31 Jan 2025 1:30 PM ISTBasel: Roche has announced that Wafaa Mamilli will join the company as Chief Digital Technology Officer (CDTO), reporting to Group CEO, Thomas...
Roche receives USFDA clearance with CLIA waiver for cobas liat sexually transmitted infection multiplex assay panels Ruchika Sharma26 Jan 2025 10:30 AM ISTBasel: Roche has announced that the U.S. Food and Drug Administration (FDA) has granted 510(k) clearance and Clinical Laboratory Improvement...
Roche gets USFDA clearance for highly-sensitive test to aid clinicians in diagnosing B-cell lymphoma Ruchika Sharma14 Jan 2025 4:06 PM ISTBasel: Roche has announced that it has received 510(k) clearance from the United States Food and Drug Administration (FDA) for its...
